Read this company snapshot
Daily valuation snapshot
Alterity Therapeutics Limited American Depositary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $3.12
- Market capitalization (USD)
- $1,129,233.51
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.04
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ATHE in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ATHE in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing ATHE with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $3.12 |
| Market capitalization (USD) | $1,129,233.51 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.04 |
No matching rows. Clear the filter to see all records.
Read ATHE's valuation metrics
Company size
Alterity Therapeutics Limited American Depositary Shares's recorded market capitalization is $1,129,233.51. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
ATHE's recorded price-to-book ratio is 0.04. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Alterity Therapeutics Limited American Depositary Shares with Aurora
Use the snapshot above to ask a specific question about ATHE. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ATHE's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.